Concurrent progress of reprogramming and gene correction to overcome therapeutic limitation of mutant ALK2-iPSC. - Wikidata - awgldk - TriplyDB

Concurrent progress of reprogramming and gene correction to overcome therapeutic limitation of mutant ALK2-iPSC.

Concurrent progress of reprogramming and gene correction to overcome therapeutic limitation of mutant ALK2-iPSC.

http://www.wikidata.org/entity/Q37057699

about

Urine-derived induced pluripotent stem cells as a modeling tool to study rare human diseases Integrating Gene Correction in the Reprogramming and Transdifferentiation Processes: A One-Step Strategy to Overcome Stem Cell-Based Gene Therapy Limitations.Therapeutic gene editing: delivery and regulatory perspectives Application of human induced pluripotent stem cells to model fibrodysplasia ossificans progressiva.Fibrodysplasia ossificans progressiva: Basic understanding and experimental models.AMPK downregulates ALK2 via increasing the interaction between Smurf1 and Smad6, leading to inhibition of osteogenic differentiation.Generation of urine-derived induced pluripotent stem cells from a patient with phenylketonuria.

P2860

Q28073204-E109A7CD-E295-410F-B47E-09941AA76710 Q37542688-9FB3B943-F7AC-4716-A9B8-750EC7583DD8 Q39230418-959DBA26-0998-4164-8ADE-831F62457265 Q39439904-760358F6-90CB-499E-97CE-0DC0C076A0D5 Q47114501-68D6881E-1F43-44B4-95DB-27691DB7B656 Q47895489-700661D3-E0E7-4058-B17E-1A149532EE8B Q55187124-0B162F50-B0CB-4D01-864E-8BE19B469A17

P2860

Concurrent progress of reprogramming and gene correction to overcome therapeutic limitation of mutant ALK2-iPSC.

http://www.wikidata.org/entity/Q37057699

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 03 June 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Concurrent progress of reprogr ...... imitation of mutant ALK2-iPSC.

@en

Concurrent progress of reprogr ...... imitation of mutant ALK2-iPSC.

@nl

type

label

Concurrent progress of reprogr ...... imitation of mutant ALK2-iPSC.

@en

Concurrent progress of reprogr ...... imitation of mutant ALK2-iPSC.

@nl

prefLabel

Concurrent progress of reprogr ...... imitation of mutant ALK2-iPSC.

@en

Concurrent progress of reprogr ...... imitation of mutant ALK2-iPSC.

@nl

P1433

Q37057699-BBC41E61-16A1-4B0B-9689-A3B060FB95D2

P1476

Q37057699-EF732A8A-08B0-4E9F-AD1D-BE2EADFAA7A7

P2093

Q37057699-3050833C-84E8-4DA3-8D9C-511B7571C975

Q37057699-500233BB-CABF-4072-800D-C70A45FE8D0F

Q37057699-5C38FA14-E1D2-4A66-BBF6-A1D8BD8ECD48

Q37057699-638918C7-6D32-4E9E-8AF4-0ED2E3579FB3

Q37057699-93032E4F-83E1-4B51-8346-C4C9E7451D4A

Q37057699-E86BEAF3-96D2-4750-89E5-C21C5D653EDC

Q37057699-F079F6CF-C568-487E-A924-C1640DC3BEA9

P2860

Q37057699-05B024D0-F0F0-4A90-9876-A4D306DF9B50

Q37057699-18C89933-2FDA-4246-89A2-10A9CD11FDD2

Q37057699-23BEF2C4-0D1B-455C-8AB8-AF09B83BAB21

Q37057699-24ADB911-467E-49A0-9195-0EDCC2184CE4

Q37057699-30DF25DC-B26A-4F27-805E-B6E1475CF7AF

Q37057699-33D64379-EE7B-49BF-9A2F-656434053C71

Q37057699-348E7027-D446-41F9-919B-BDBE354FC400

Q37057699-4A1775D9-BD43-40B0-BD0B-7227D95DD8E4

Q37057699-4AF99C01-D9DF-4AE7-8E77-DF2E43F512E5

Q37057699-4D9DC430-9F5A-413B-8BEC-C522C6A44477

P2888

Q37057699-6FC9AC8A-87C9-4E2A-930D-150016806C5D

P304

Q37057699-0FC52D91-69CC-4735-B44A-F89E7D7FDEB3

P31

Q37057699-32651DED-16EE-44E5-973B-84961BF182D6

P356

Q37057699-21EF8029-2E02-4A48-83EB-41E9E6357697

P433

Q37057699-4B964BE1-7EFE-4E1A-B4EB-C07DB2816745

P478

Q37057699-A93473FD-FCEA-4B14-9477-C8199F88E073

P50

Q37057699-8F0DA7D7-A17D-451D-8840-C5C5B87C99F2

P577

Q37057699-ABFABBDE-2C93-43E2-8B03-88FE743F28F3

P698

Q37057699-4BD643BA-447C-440A-8D35-6A0C25B9B424

P932

Q37057699-B719E9FF-3010-47D7-AB37-B92A73B683FB

P356

P1433

Experimental and Molecular Medicine

P1476

Concurrent progress of reprogr ...... limitation of mutant ALK2-iPSC

@en

P2093

Bu-Yeo Kim

http://www.w3.org/2001/XMLSchema#string

Eun Jeong Gweon

http://www.w3.org/2001/XMLSchema#string

Hyunjun Ahn

http://www.w3.org/2001/XMLSchema#string

SangKyun Jeong

http://www.w3.org/2001/XMLSchema#string

Seo-Young Lee

http://www.w3.org/2001/XMLSchema#string

So Min Lee

http://www.w3.org/2001/XMLSchema#string

Sun-Ku Chung

http://www.w3.org/2001/XMLSchema#string

P2860

A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva

Fanconi anemia proteins FANCA, FANCC, and FANCG/XRCC9 interact in a functional nuclear complex

Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain

RNA-guided human genome engineering via Cas9

Multiplex genome engineering using CRISPR/Cas systems

Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells

Evidence for at least eight Fanconi anemia genes

A comparison of normalization methods for high density oligonucleotide array data based on variance and bias

Enhancing gene targeting with designed zinc finger nucleases

Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease

P2888

P304

e237

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/EMM.2016.43

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-06-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27256111

http://www.w3.org/2001/XMLSchema#string

P932

4929693

http://www.w3.org/2001/XMLSchema#string